Sign in with Google. Opens in new tab
ENTITY
SMARTSCORE: 3.2/5

DBV Technologies SA (DBVT US)

1
Analysis
Health CareFrance
DBV Technologies SA operates as a biopharmaceutical firm. The Company develops products and immunotherapies for the diagnosis and treatment of various food allergies. DBV Technologies delivers biological immunoactive compounds, such as allergens, to the immune system by targeting the antigen-presenting cells present in skin.
more
06 Dec 2020 22:26

House Passes "Delisting Act" Giving SEC 90 Days to Write Its Rules (And Yes, More Bark Than Bite)

The U.S. House of Representatives passed Senate Bill 945, the "Holding Foreign Companies Accountable Act." New details support the notion that S945...

Logo
431 Views
Share
No more insights
x